Skip to main content

Peer Review reports

From: Comparative efficacy and safety of first-line treatments for advanced non-small cell lung cancer with ALK-rearranged: a meta-analysis of clinical trials

Original Submission
18 May 2021 Submitted Original manuscript
2 Jul 2021 Reviewed Reviewer Report - Kentaro Ito
9 Aug 2021 Reviewed Reviewer Report - Francesco Facchinetti
19 Sep 2021 Author responded Author comments - Hai-bo Zhang
Resubmission - Version 2
19 Sep 2021 Submitted Manuscript version 2
21 Sep 2021 Author responded Author comments - Hai-bo Zhang
Resubmission - Version 3
21 Sep 2021 Submitted Manuscript version 3
12 Oct 2021 Author responded Author comments - Hai-bo Zhang
Resubmission - Version 4
12 Oct 2021 Submitted Manuscript version 4
Publishing
30 Oct 2021 Editorially accepted
26 Nov 2021 Article published 10.1186/s12885-021-08977-0

You can find further information about peer review here.

Back to article page